Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots
β Scribed by Liapis, E.; McLuckie, K. I.E.; Lewis, P. D.; Farmer, P. B.; Brown, K.
- Book ID
- 126840948
- Publisher
- Oxford University Press
- Year
- 2008
- Tongue
- English
- Weight
- 545 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0305-1048
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract This study was conducted to evaluate the significance of circulating free DNA (CFDNA), p53 antibody (p53βAb) and mutations of __KRAS__ gene in the development of endometrial cancer (EC). A total of 109 patients with EC (87 patients with Type I and 22 patients with Type II) took part in
## Abstract The tumor suppressor p53 is frequently mutated in cancer. We have investigated the regulation of P53 in p53 wild type mouse hepatoma cells (line 55.1c), in p53 heterozygeously mutated cells (56.1b) and in p53 defective cells (lines 56.1d, 70.4 and HUH7) under various experimental settin